We are live on ! Find out more
ALNA

Allena Pharmaceuticals
ALNA

Delisted

ALNA was delisted on the 7th of September, 2022.

Back to rankings

42 hedge funds and large institutions have $183M invested in Allena Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

15% more capital invested

Capital invested by funds: $158M → $183M (+$24.5M)

11% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 9

5% more funds holding

Funds holding: 40 → 42 (+2)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
42
Holders Change
+2
Holders Change %
+5%
% of All Funds
0.96%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
9
Increased
10
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$3.7M
2
SFM
Sphera Funds Management
Israel
+$712K
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$703K
4
Millennium Management
Millennium Management
New York
+$582K
5
BCM
Bridgeway Capital Management
Texas
+$509K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$6.09M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.52M
3
JP Morgan Chase
JP Morgan Chase
New York
-$1.35M
4
Goldman Sachs
Goldman Sachs
New York
-$171K
5
DIM
DC Investments Management
Virginia
-$116K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$103K +$55.5K +6,641 +246%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$94K – – –
Deutsche Bank
28
Deutsche Bank
Germany
$75K -$40.8K -4,889 -41%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$74K – – –
AIG
30
American International Group
New York
$38K -$1.54K -185 -5%
SO
31
STRS Ohio
Ohio
$16K – – –
Barclays
32
Barclays
United Kingdom
$13K +$2.24K +268 +31%
CHP
33
Cable Hill Partners
Oregon
$13K +$8.35K +1,000 New
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$10.2K -$961 -115 -11%
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$10K -$977 -117 -12%
Legal & General Group
36
Legal & General Group
United Kingdom
$10K – – –
Citigroup
37
Citigroup
New York
$8K +$877 +105 +17%
AIP
38
Ameritas Investment Partners
Nebraska
$5K – – –
Bank of America
39
Bank of America
North Carolina
$4K -$2.32K -278 -40%
DZ Bank
40
DZ Bank
Germany
$3K +$2.51K +300 New
MAM
41
Meeder Asset Management
Ohio
$1K +$869 +104 New
DM
42
Deerfield Management
New York
– -$6.09M -605,100 Closed
DIM
43
DC Investments Management
Virginia
– -$116K -11,568 Closed
TA
44
Teachers Advisors
New York
– -$62K -6,190 Closed
TRCT
45
Tower Research Capital (TRC)
New York
– -$22K -2,232 Closed
UBS Group
46
UBS Group
Switzerland
– -$20K -1,974 Closed
Parallax Volatility Advisers
47
Parallax Volatility Advisers
California
– -$8K -840 Closed
CCA
48
Catalyst Capital Advisors
New York
– -$4K -420 Closed
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– +$58 +7 New
1
2

ALNA Hedge Fund Activity: Q1 2018 in Review

42 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q1 2018, worth a combined $183M — up 15% from $158M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ALNA positions and 7 closed out — a net gain of 2 holders — while 10 added to existing stakes and 9 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $3.7M. The largest seller was Deerfield Management, exiting entirely with an estimated $6.09M sold.

  • 42 institutional investors held Allena Pharmaceuticals (ALNA) as of Q1 2018, up from 40 in Q4 2017.
  • Funds reported $183M of Allena Pharmaceuticals stock for Q1 2018, up 15% quarter-over-quarter.
  • 9 funds opened new Allena Pharmaceuticals positions in Q1 2018 and 7 closed out, a net change of +2 holders.
  • The largest Allena Pharmaceuticals buyer in Q1 2018 was Morgan Stanley, an estimated $3.7M added.
  • The largest Allena Pharmaceuticals seller in Q1 2018 was Deerfield Management, an estimated $6.09M sold.

Based on aggregated 13F filings for Q1 2018.